Clinical trial
Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A…
NCT00205751 · Austrian Forum Against Cancer, Other · Completed
Key facts
| NCT number | NCT00205751 |
|---|---|
| Title | Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy |
| Official title | International, Multi-center, Prospective, Double Randomized, Open Phase III Study Evaluating Thalidomide/Dexamethasone Versus Melphalan/Prednisone as Induction Therapy and Thalidomide/Interferon-alpha Versus Interferon-alpha as Maintenance Therapy in Newly Diagnosed Patients With Multiple Myeloma |
| Lead sponsor | Austrian Forum Against Cancer, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Thalidomide/Dexamethasone vs Melphalan/Prednisone |
| Enrollment | 350 |
| Start date | Aug 1, 2001 |
| Completion | Oct 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 25, 2013 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: